These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 10804727

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
    Tobari S, Ikeda Y, Takami H.
    J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
    [Abstract] [Full Text] [Related]

  • 23. Increase in pulmonary arterial diameter under prostaglandin E1 therapy in infants with cyanotic congenital heart disease.
    Ito T, Harada K, Tamura M, Takada G.
    Pediatr Cardiol; 1998 Nov; 19(5):404-7. PubMed ID: 9703565
    [Abstract] [Full Text] [Related]

  • 24. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
    Ohara T, Ogata H, Fujiyama J, Murata Y, Abe J, Kakuta K, Hayamizu S, Kameyama S, Yoshida Y.
    Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
    [Abstract] [Full Text] [Related]

  • 25. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
    Reddy SC, Saxena A.
    Indian J Pediatr; 1998 Jun; 65(2):211-6. PubMed ID: 10771966
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prostaglandin E1 in infants with critical congenital heart disease.
    Dungan WT.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Jan; 1(1):71-4. PubMed ID: 2454319
    [No Abstract] [Full Text] [Related]

  • 28. Prostaglandin E1 in infants with congenital diaphragmatic hernia (CDH) and life-threatening pulmonary hypertension.
    Le Duc K, Mur S, Sharma D, Aubry E, Recher M, Rakza T, Storme L, Center for Rare Disease «Congenital Diaphragmatic Hernia».
    J Pediatr Surg; 2020 Sep; 55(9):1872-1878. PubMed ID: 32061366
    [Abstract] [Full Text] [Related]

  • 29. Liposomal prostaglandin E1 enhances optic nerve head blood flow in cats.
    Kitanishi K, Harino S, Suzuki M, Okamoto N, Reinach P.
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):115-22. PubMed ID: 11324979
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L, Xing W, Xun H, Gui-fu W, Cheng-heng H, Zhi-min D.
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Supportive and emergency use of prostaglandin in the neonate with congenital heart disease.
    Hussain A, al Khudhairi D.
    Middle East J Anaesthesiol; 1993 Feb; 12(1):73-81. PubMed ID: 8316154
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lipo-prostaglandin E1 increases immediate arterial maximal flow velocity of free flap in patients undergoing reconstructive surgery.
    Jin SJ, Suh HP, Lee J, Hwang JH, Hong JPJ, Kim YK.
    Acta Anaesthesiol Scand; 2019 Jan; 63(1):40-45. PubMed ID: 30058113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.